Remember:
RaceOncology: we are really focused on achieving a return for our shareholders, not just giving ourselves cushy, overpaid positions.
A major reason for this is we all have significant skin in the game from shares we have bought with our own money. This is a culture we all want to see continued as new people join the company. Shareholders first, management second.
No magic massive CR like MSB and a tight held positions by management who clearly see the opportunities and their efforts to prove without any doubt the cancer drug Bisantrene
Ann: Cleansing Notice, page-12
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
-0.045(2.73%) |
Mkt cap ! $273.5M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.66 | $1.61 | $159.4K | 98.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5684 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.62 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |